Authors


Matt Hoffman

Latest:

Paxlovid Regimen Safe, But Not Effective for Postacute Sequelae of COVID-19

A newly published study suggests that a 15-day regimen, while safe, did not statistically separate from a placebo comparator group in main outcomes for PASC of SARS-CoV-2 infection.


DAVID VAN DUIN, MD, PHD

Latest:

The Multi-Drug Resistant Organism Network

A collaborative, international effort aims to answer tough antimicrobial resistance questions.


Laurie Saloman

Latest:

Preventing Multidrug-Resistant Spread in Healthcare Facilities

The interconnectedness of many healthcare facilities such as nursing homes, hospitals, and long-term acute-care hospitals means a significant chance of multidrug-resistant organism transmission when patients shuttle between facilities.


Brian McCullough, PharmD, BCPS

Latest:

Shoutout to the Stewards: Holiday Edition

Contagion® radio is here to bring joy with every new antibiotic alert!


Katie Eder

Latest:

How Obamacare Will Affect HIV/AIDS Prevention

Noting successful HIV/AIDS prevention efforts rely on early diagnosis, an analysis estimates that improved access to health insurance through the Affordable Care Act will increase the number of patients getting tested for HIV by nearly 500,000 over a 5-year period, though that impact would be amplified if all US states opted to expand Medicaid coverage.


Contagion Staff

Latest:

President Trump and First Lady Test Positive for COVID-19

President Donald Trump broke the news last night via Twitter.


Shelby Leheny, PharmD, BS

Latest:

Taking A Closer Look at Shingrix: The New Shingles Vaccine

The only way individuals can reduce their risk of getting shingles is to get vaccinated; luckily, a new vaccine has recently been approved by the FDA.


LAUREN MUSSER, MD (RESIDENT)

Latest:

An Unknown Contagious Rash: Case Report and Literature Review of Norwegian Crusted Scabies

A patient with HIV and skin lesions should trigger a broad differential.


Samantha DiGrande

Latest:

Fecal Transplant Benefits C diff Patients Coinfected With COVID-19

Treating Clostridioides difficile infection is complicated in patients coinfected with COVID-19. However, a new study suggests a significant benefit of fecal microbiota transplant (FMT) in these coinfected patients.


Michael B. Henry, MD

Latest:

Four Fungal Horsemen: Emerging Trends in Fungal Disease Epidemiology

New public health perspectives on aspergillosis, sporotrichosis, histoplasmosis, and coccidioidomycosis.



E. Kelly Hester, PharmD

Latest:

Antiretroviral Safety in Pregnancy: Focus on Dolutegravir, Integrase Inhibitors, and Neural Tube Defects

There has been increasing interest in the association between neural tube defects, dolutegravir, and integrase inhibitors as a class since 4 cases were reported in 2018.


Colleen Hall

Latest:

Pediatric Hexavalent Combination Vaccine Approved by FDA

The vaccine is approved as a 3-dose series, which consists of a 0.5 mL intramuscular injection, administered at 2, 4, and 6 months of age.


DANIEL B. CHASTAIN, PHARMD, BCIDP, AAHIVP*

Latest:

Alternative Antiretroviral Medication Delivery Systems Emerge to Treat, Prevent HIV Infection

Novel modes of delivery are imperative to improve HIV suppression and prevent transmission.


Jenna Payesko

Latest:

FDA Grants QIDP & Fast Track Designations for SCY-078 to Treat Vulvovaginal Candidiasis

The FDA has granted QIDP and Fast Track Designations for the oral formulation of SCY-078 for the treatment of vulvovaginal candidiasis.



Mathew Shanley

Latest:

Strategic Alliance Formed to Advance RNAi Therapeutics for Infectious Diseases

Alnylam Pharmaceuticals announces exclusive licensing agreement with Vir Biotechnology for the development and commercialization of RNA Interference therapeutics for infectious diseases.


Monika Schneider, PhD

Latest:

New Rules Expand Application of the NTAP Program for Innovative Antibiotics

To better support the use of critical antibiotics, the Centers for Medicare & Medicaid Services revised the rules governing reimbursement for qualifying antibiotic products. For these changes to succeed, hospital systems will need to make adjustments.


Nicola M. Parry, BVSc, MRCVS, MSc, DACVP, FRSPH, ELS

Latest:

FDA Guidance Synchronizes Launch of Antimicrobial and AST Device

The FDA has finalized its guidance on how to synchronize development of antimicrobials and antimicrobial susceptibility test devices.


Ginny Marmolejos, MD

Latest:

Final Diagnosis: Disseminated Kaposi Sarcoma With Tonsillar and Pulmonary Involvement

A shocking find on a CT scan leads to an unexpected diagnosis.



Brian Hoyle, PhD

Latest:

Vaccination in 2019: Daunting Challenges and Optimism

The Closing Plenary of IDWeek 2019 discussed the challenges of vaccination and the optimism that we may be on the path to eradicating some global infectious diseases.


Michaela Fleming

Latest:

Don't Rush Science: Maintaining Ethics in Exploring Countermeasures for COVID-19

Michael K. Gusmano, PhD, discusses the importance of maintaining ethical standards in research evaluating potential therapeutics and vaccines for COVID-19.


Liza Vaezi, MSc, Pharm D, DPLA, BCPS-AQ ID

Latest:

Can Fidaxomicin Provide Effective C difficile-Associated Diarrhea Prophylaxis for HSCT Recipients?

Clostridium difficile rates in stem cell transplant patients are approximately 9 times greater than in hospitalized patients, with rates about twice as high in allogeneic vs autologous transplants.



Colleen Owens

Latest:

ACIP Endorses Shingrix As Preferred Shingles Vaccine for Adults Aged 50 & Older

The CDC’s ACIP recommends newly FDA-approved Shingrix as the preferred vaccine for the prevention of shingles in individuals 50 years of age or older.


Jeremy D. Young, MD, MPH

Latest:

New and Pipeline Antiretroviral Agents for the Treatment of HIV-1 Infection

This article seeks to review newer ART agents, as well as those in later stages of drug development, for the treatment of HIV-1 infection.


SARAH BATTLE, MD

Latest:

Get Off the SOFA! Introducing the Quick Pitt Bacteremia Score

The quick Pitt Bacteremia Score offers accuracy comparable to the original version's across multiple infections, and maintains ease of use.


Aileen Ahiskali, PharmD

Latest:

The Great Debate: Polymyxin B Versus Polymyxin E

As we await novel compounds from a relatively apathetic industry, we are resurrecting antibiotics of which we have an outdated understanding. and that carry the potential for substantial side effects: polymyxins.


Brionna Matt, DO

Latest:

Biktarvy: A Regimen of Choice for HIV Therapy

The new single-tablet regimen provides a safe and effective treatment option for patients with HIV.

© 2024 MJH Life Sciences

All rights reserved.